Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Biomarin Pharmaceutical Inc (BMRN)  
$88.63 1.44 (1.6%) as of 4:30 Fri 4/19


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 188,370,000
Market Cap: 16.70(B)
Last Volume: 1,778,607 Avg Vol: 1,398,026
52 Week Range: $76.22 - $99
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Other

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  811
Guru Rank Value     : 0.9
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   BioMarin Pharmaceutical is a biotechnology company that develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Co.'s commercial products are Aldurazyme (laronidase) for Mucopolysaccharidosis I; Brineura (cerliponase alfa) for the treatment of late infantile neuronal ceroid lipofuscinosis type 2; Kuvan (sapropterin dihydrochloride) for the treatment of phenylketonuria; Naglazyme (galsulfase) the treatment of Mucopolysaccharidosis VI ; Palynziq (pegvaliase-pqpz) for adult patients with phenylketonuria; and Vimizim (elosulfase alpha) for the treatment of Mucopolysaccharidosis IV Type A.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 3,625
Total Buy Value $0 $0 $0 $314,469
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 116,079 189,843 233,203 571,547
Total Sell Value $10,217,149 $17,085,208 $20,986,230 $54,848,304
Total People Sold 5 5 6 7
Total Sell Transactions 11 17 23 53
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 1303
  Page 29 of 53  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Mueller Brian VP, Corporate Controller   •       –      –    2011-04-29 4 A $11.64 $17,466 D/D 1,501 2,613     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2011-04-29 4 A $11.64 $21,249 D/D 1,826 91,893     -
   Aselage Steve EVP, Chief Business Officer   •       –      –    2011-04-29 4 A $11.64 $18,583 D/D 1,597 31,478     -
   Davis George Eric SVP, General Counsel   •       –      –    2011-04-29 4 A $11.64 $17,805 D/D 1,530 29,431     -
   Wood Mark VP, Human Resources   •       –      –    2011-04-25 4 S $26.35 $43,377 D/D (1,646) 14,243     -
   Wood Mark VP, Human Resources   •       –      –    2011-04-25 4 OE $14.39 $25,815 D/D 1,646 15,889     -
   Fuchs Henry J EVP, Chief Medical Officer   •       –      –    2011-04-20 4 S $27.00 $355,455 D/D (13,165) 22,835     -
   Fuchs Henry J EVP, Chief Medical Officer   •       –      –    2011-04-20 4 OE $11.05 $55,250 D/D 5,000 36,000     -
   Wood Mark VP, Human Resources   •       –      –    2011-04-13 4 S $26.00 $18,408 D/D (708) 14,243     -
   Wood Mark VP, Human Resources   •       –      –    2011-04-13 4 OE $17.33 $12,314 D/D 708 14,951     -
   Davis George Eric SVP, General Counsel   •       –      –    2011-04-13 4 AS $26.50 $100,700 D/D (3,800) 27,901     -
   Davis George Eric SVP, General Counsel   •       –      –    2011-04-13 4 OE $11.74 $44,612 D/D 3,800 31,701     -
   Fuchs Henry J EVP, Chief Medical Officer   •       –      –    2011-04-01 4 S $25.45 $63,626 D/D (2,500) 31,000     -
   Fuchs Henry J EVP, Chief Medical Officer   •       –      –    2011-04-01 4 OE $11.05 $27,625 D/D 2,500 33,500     -
   Wood Mark VP, Human Resources   •       –      –    2011-03-22 4 S $23.42 $21,970 D/D (938) 14,243     -
   Wood Mark VP, Human Resources   •       –      –    2011-03-22 4 OE $14.39 $13,498 D/D 938 15,181     -
   Davis George Eric SVP, General Counsel   •       –      –    2011-03-09 4 S $24.49 $146,966 D/D (6,000) 27,901     -
   Davis George Eric SVP, General Counsel   •       –      –    2011-03-09 4 OE $11.74 $70,440 D/D 6,000 33,901     -
   Mueller Brian VP, Corporate ControllerOffice   •       –      –    2011-03-02 3 IO $0.00 $0 D/D 0 1,112     -
   Fuchs Henry J EVP, Chief Medical Officer   •       –      –    2011-03-01 4 S $24.18 $20,167 D/D (834) 31,000     -
   Fuchs Henry J EVP, Chief Medical Officer   •       –      –    2011-03-01 4 OE $11.05 $9,216 D/D 834 31,834     -
   Lapalme Pierre Director   –       •      –    2011-02-24 4 S $24.94 $374,096 D/D (15,000) 18,750     -
   Lapalme Pierre Director   –       •      –    2011-02-24 4 OE $5.92 $88,800 D/D 15,000 33,750     -
   Lapalme Pierre Director   –       •      –    2011-02-23 4 S $26.00 $2,600 D/D (100) 18,750     -
   Lapalme Pierre Director   –       •      –    2011-02-23 4 OE $8.47 $847 D/D 100 18,850     -
  1303 Records found
  Previous  20  21  22  23  24  25  26  27  28  29  Next   
  Page 29 of 53
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us